HDAC9 and diabetes mellitus: While calcineurin/NFAT and CaMKII/HDAC hypertrophy pathways (as well as the PI3K/Akt and MAPK/ERK signaling) are activated in both pregnancy and diabetes, the outcomes are divergent, likely due to differences in the duration of pathway activation and the surrounding physiological context.